Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |